The Journal of Urology
Volume 182, Issue 3 , Pages 835-843 , September 2009

Proteomics and Opportunities for Clinical Translation in Urological Disease

  • Ali R. Vaezzadeh

      Affiliations

    • Department of Urology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts
    • Proteomics Center, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts
    • ,
  • Hanno Steen

      Affiliations

    • Department of Pathology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts
    • Proteomics Center, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts
    • ,
  • Michael R. Freeman

      Affiliations

    • Department of Urology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts
    • ,
  • Richard S. Lee

      Affiliations

    • Department of Urology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts
    • Proteomics Center, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts
    • Corresponding Author InformationCorrespondence: Department of Urology, Children's Hospital Boston, Boston, Massachusetts 02115 (telephone: 617-355-7796; FAX: 617-730-0474)

Received 24 September 2008

References 

  1. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422:198
  2. Pennisi E. Genetics (Working the (gene count) numbers: finally, a firm answer?). Science. 2007;316:1113
  3. Kelleher NL. Top-down proteomics. Anal Chem. 2004;76:197A
  4. Link AJ, Eng J, Schieltz DM, et al. Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol. 1999;17:676
  5. Fenn JB, Mann M, Meng CK, et al. Electrospray ionization for mass spectrometry of large biomolecules. Science. 1989;246:64
  6. Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem. 1988;60:2299
  7. Bodnar WM, Blackburn RK, Krise JM, et al. Exploiting the complementary nature of LC/MALDI/MS/MS and LC/ESI/MS/MS for increased proteome coverage. J Am Soc Mass Spectrom. 2003;14:971
  8. Glish GL, Burinsky DJ. Hybrid mass spectrometers for tandem mass spectrometry. J Am Soc Mass Spectrom. 2008;19:161
  9. Poon TC. Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices. Expert Rev Proteomics. 2007;4:51
  10. Issaq H, Veenstra T. Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE): advances and perspectives. Biotechniques. 2008;44:697
  11. Pappin DJ, Hojrup P, Bleasby AJ. Rapid identification of proteins by peptide-mass fingerprinting. Curr Biol. 1993;3:327
  12. Hernandez P, Muller M, Appel RD. Automated protein identification by tandem mass spectrometry: issues and strategies. Mass Spectrom Rev. 2006;25:235
  13. Nesvizhskii AI, Aebersold R. Interpretation of shotgun proteomic data: the protein inference problem. Mol Cell Proteomics. 2005;4:1419
  14. Ong SE, Blagoev B, Kratchmarova I, et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics. 2002;1:376
  15. Gygi SP, Rist B, Gerber SA, et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol. 1999;17:994
  16. Ross PL, Huang YN, Marchese JN, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics. 2004;3:1154
  17. Yao X, Afonso C, Fenselau C. Dissection of proteolytic 18O labeling: endoprotease-catalyzed 16O-to-18O exchange of truncated peptide substrates. J Proteome Res. 2003;2:147
  18. Old WM, Meyer-Arendt K, Aveline-Wolf L, et al. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell Proteomics. 2005;4:1487
  19. Gerber SA, Rush J, Stemman O, et al. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci U S A. 2003;100:6940
  20. Collins MO, Yu L, Choudhary JS. Analysis of protein phosphorylation on a proteome-scale. Proteomics. 2007;7:2751
  21. Temporini C, Calleri E, Massolini G, et al. Integrated analytical strategies for the study of phosphorylation and glycosylation in proteins. Mass Spectrom Rev. 2008;27:207
  22. Orchard S, Hermjakob H, Julian RK, et al. Common interchange standards for proteomics data: public availability of tools and schema. Proteomics. 2004;4:490
  23. Lescuyer P, Hochstrasser D, Rabilloud T. How shall we use the proteomics toolbox for biomarker discovery?. J Proteome Res. 2007;6:3371
  24. Howard BA, Wang MZ, Campa MJ, et al. Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis. Proteomics. 2003;3:1720
  25. Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics. 2006;5:573
  26. Yamamoto T, Langham RG, Ronco P, et al. Towards standard protocols and guidelines for urine proteomics: a report on the Human Kidney and Urine Proteome Project (HKUPP) symposium and workshop, 6 October 2007, Seoul, Korea and 1 November 2007, San Francisco, CA, USA. Proteomics. 2008;8:2156
  27. Lee RS, Monigatti F, Briscoe AC, et al. Optimizing sample handling for urinary proteomics. J Proteome Res. 2008;7:4022
  28. Thongboonkerd V. Practical points in urinary proteomics. J Proteome Res. 2007;6:3881
  29. Spahr CS, Davis MT, McGinley MD, et al. Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. I. Profiling an unfractionated tryptic digest. Proteomics. 2001;1:93
  30. Castagna A, Cecconi D, Sennels L, et al. Exploring the hidden human urinary proteome via ligand library beads. J Proteome Res. 2005;4:1917
  31. Adachi J, Kumar C, Zhang Y, et al. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 2006;7:R80
  32. Sun W, Li F, Wu S, et al. Human urine proteome analysis by three separation approaches. Proteomics. 2005;5:4994
  33. Lee RS, Monigatti F, Lutchman M, et al. Temporal variations of the postnatal rat urinary proteome as a reflection of systemic maturation. Proteomics. 2008;8:1097
  34. O'Riordan E, Orlova TN, Podust VN, et al. Characterization of urinary peptide biomarkers of acute rejection in renal allografts. Am J Transplant. 2007;7:930
  35. Clarke W, Silverman BC, Zhang Z, et al. Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg. 2003;237:660
  36. Haubitz M, Wittke S, Weissinger EM, et al. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int. 2005;67:2313
  37. Schiffer E, Mischak H, Novak J. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS. Proteomics. 2006;6:5615
  38. Weissinger EM, Wittke S, Kaiser T, et al. Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int. 2004;65:2426
  39. Decramer S, Wittke S, Mischak H, et al. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med. 2006;12:398
  40. Rogers MA, Clarke P, Noble J, et al. Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. Cancer Res. 2003;63:6971
  41. Theodorescu D. Cryotherapy for prostate cancer: what we know, what we need to know. J Urol. 2008;180:437
  42. Smalley DM, Sheman NE, Nelson K, et al. Isolation and identification of potential urinary microparticle biomarkers of bladder cancer. J Proteome Res. 2008;7:2088
  43. Saito M, Kimoto M, Araki T, et al. Proteome analysis of gelatin-bound urinary proteins from patients with bladder cancers. Eur Urol. 2005;48:865
  44. Irmak S, Tilki D, Heukeshoven J, et al. Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer. Proteomics. 2005;5:4296
  45. Celis JE, Gromova I, Moreira JM, et al. Impact of proteomics on bladder cancer research. Pharmacogenomics. 2004;5:381
  46. Orenes-Pinero E, Corton M, Gonzalez-Peramato P, et al. Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach. J Proteome Res. 2007;6:4440
  47. Langbein S, Lehmann J, Harder A, et al. Protein profiling of bladder cancer using the 2D-PAGE and SELDI-TOF-MS technique. Technol Cancer Res Treat. 2006;5:67
  48. McDonnell LA, Heeren RM. Imaging mass spectrometry. Mass Spectrom Rev. 2007;26:606
  49. Xu BJ, Shyr Y, Liang X, et al. Proteomic patterns and prediction of glomerulosclerosis and its mechanisms. J Am Soc Nephrol. 2005;16:2967
  50. Meistermann H, Norris JL, Aerni HR, et al. Biomarker discovery by imaging mass spectrometry: transthyretin is a biomarker for gentamicin-induced nephrotoxicity in rat. Mol Cell Proteomics. 2006;5:1876
  51. Chaurand P, Rahman MA, Hunt T, et al. Monitoring mouse prostate development by profiling and imaging mass spectrometry. Mol Cell Proteomics. 2008;7:411
  52. Everley PA, Krijgsveld J, Zetter BR, et al. Quantitative cancer proteomics: stable isotope labeling with amino acids in cell culture (SILAC) as a tool for prostate cancer research. Mol Cell Proteomics. 2004;3:729
  53. MacLellan DL, Steen H, Adam RM, et al. A quantitative proteomic analysis of growth factor-induced compositional changes in lipid rafts of human smooth muscle cells. Proteomics. 2005;5:4733
  54. Han CL, Chien CW, Chen WC, et al. A multiplexed quantitative strategy for membrane proteomics: opportunities for mining therapeutic targets for autosomal-dominant polycystic kidney disease. Mol Cell Proteomics. 2008;7:1983
  55. Xu D, Suenaga N, Edelmann MJ, et al. Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach. Mol Cell Proteomics. 2008;7:2215

 Supported by NIH P50DK65298 (MRF), NIH K08DK077836 (RSL) and a Children's Hospital Boston Career Development Fellowship (RSL).

 The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

PII: S0022-5347(09)01138-0

doi: 10.1016/j.juro.2009.05.001

The Journal of Urology
Volume 182, Issue 3 , Pages 835-843 , September 2009

Article Tools

* Image Usage & Resolution